Chandan Healthcare Ltd

Chandan Healthca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chandan Healthcare Ltd

₹ 202 -0.44%
13 Jun 3:42 p.m.
Company website NSE - SME: CHANDAN
About

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Key Points

Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points

Website NSE - SM
  • Market Cap ₹ 494 Cr.
  • Current Price ₹ 202
  • High / Low ₹ 215 / 140
  • Stock P/E 22.3
  • Book Value ₹ 50.1
  • Dividend Yield 0.00 %
  • ROCE 28.1 %
  • ROE 27.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.5%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -20.5%
  • Working capital days have increased from 63.0 days to 116 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
92 120
78 98
Operating Profit 14 21
OPM % 15% 18%
1 1
Interest 1 2
Depreciation 2 4
Profit before tax 11 17
Tax % 24% 27%
8 12
EPS in Rs 4.23 4.72
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
120 137 177 230
117 128 150 189
Operating Profit 2 9 26 41
OPM % 2% 7% 15% 18%
0 0 1 2
Interest 2 2 3 5
Depreciation 2 2 3 7
Profit before tax -1 5 21 32
Tax % 3% 28% 24% 27%
-1 3 16 24
EPS in Rs -0.56 1.68 8.14 9.07
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 24%
TTM: 30%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 180%
TTM: 36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 30%
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 20 20 20 24
Reserves 4 7 21 98
17 21 42 48
41 49 46 40
Total Liabilities 82 98 129 211
29 33 48 76
CWIP 0 0 0 4
Investments 6 7 4 1
46 58 77 129
Total Assets 82 98 129 211

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
6 4 2 -29
-11 -6 -15 -36
3 2 16 67
Net Cash Flow -1 0 3 2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 88 63 55 74
Inventory Days 46 71 96 106
Days Payable 185 251 112 87
Cash Conversion Cycle -51 -117 39 93
Working Capital Days 19 15 58 116
ROCE % 16% 35% 28%

Shareholding Pattern

Numbers in percentages

Mar 2025
49.43%
3.86%
6.32%
40.38%
No. of Shareholders 897

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

Credit ratings